Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosign Technologies Inc BITKF

Biosign Technologies Inc is a Canada based company engaged in the development and selling of cloud-based medical and healthcare software products. Its solutions have applications in clinic management, home care operations, health monitoring and virtual care management. The group derives its revenue from monthly recurring fees, one-time setup charges, training, professional services and the sale... see more

GREY:BITKF - Post Discussion

View:
Post by ABirdsEyeView on Dec 31, 2013 9:12am

News

 

Biosign to acquire IBL Internet for $1.96-million

2013-12-31 06:07 PT - News Release

 

Mr. Robert Kaul reports

BIOSIGN ACQUIRES IBL INTERNET BUSINESS LOGIC INC.

Biosign Technologies Inc. has entered a share purchase agreement, under which it has agreed to acquire 100 per cent of the issued and outstanding shares of St. John, N.B.-based IBL Internet Business Logic, a practice management software developer, and creator of ClinicServer and PencilThat software platforms.

Founded in 1998, IBL offers integrated clinic management software on a cloud-based 'software as a service' platform. Their ClinicServerAtrademark solution is deployed to manage over 250 clinics in Canada and the United Kingdom, and is being used by physiotherapists, chiropractors, naturopaths and similar allied health professionals. Their newly developed PencilThatA internet-based self-scheduling application is complete and ready for launch. IBL has 7 employees in Saint John, New Brunswick

Biosign will operate IBL as a wholly-owned subsidiary, while updating and integrating features from the ClinicServerAtrademark and PencilThatA platforms into the next iteration of our HealthanywhereA comprehensive healthcare software system.

The total purchase price of $1.96 million will be satisfied by way of payment of $75,000 in cash, and by the issuance of 36,000,000 common shares of Biosign at an ascribed price of $0.05 per share, being a premium to the market price at the execution date of the SPA. This transaction is subject to receipt of all necessary regulatory and mandatory government approvals. The common shares to be issued to the vendors in connection with this transaction will be subject to a regulatory hold period of 4 months and 1 day while certain selling activities are contractually restricted over a 24-month period. It is the intention of management that no new "Control Person" (as such term is defined by the TSX Venture Exchange) of the Company be created as a result of this transaction.

Biosign CEO Robert Kaul commented: "We are pleased to announce this acquisition and welcome the team at ClinicServer to the Biosign family. Biosign is in the business of delivering value to health care providers by supplying innovative software solutions. The ClinicServerAtrademark platform developed by IBL Internet Business Logic has been embraced by a growing number of allied health clinics in Canada and the United Kingdom. Our team will now integrate Biosign's unique PulsewaveAtrademark vital sign monitoring technology into ClinicServerAtrademark, and the improved system will be offered to IBL's client base as a value-added upgrade. Meanwhile, Biosign will install IBL software systems as part of the $6 million software project that Biosign announced on December 27th, 2013. These examples of early synergy prove that together, Biosign and IBL are well placed to grow quickly as an integrated technology leader in the healthcare clinic management industry around the world.

Comment by theinvestor22 on Dec 31, 2013 10:10am
Of course, we don't know the fundamentals of the acquired company, but we do know that they have an established business with a nice client base, real revenue, recurring revenue and a new application ready to go.  And, with BIO's offering, there should be lots of cross selling opportunities as well as the big deals - such as we've just witnessed - to come our way. I know, lots of ...more  
Comment by dimar66 on Dec 31, 2013 1:59pm
I don't see this as dilutive because we are trading asets for shares, the fact that the deal was at a premium to market and was almost all in shares tells me that IBL management see this as a good investment.  There must be a synergy there that has created expectations. $75,000 in cash, and by the issuance of 36,000,000 common shares of Biosign at an ascribed price of $0.05 per share ...more  
Comment by bluepen1 on Dec 31, 2013 2:00pm
Now that they seem to have a complete package to offer, and a sales contract to back that up, hopefully this is the end of the dilution and from now on we'll just see additional revenue. As the CEO said in the conference call, they are only going after large clients that will allow BIO to grow very quickly...... hopefully much more to come in the new year.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities